Phase 3 clinical study of MRA in patients with systemic juvenile idiopathic arthritis (sJIA)
Latest Information Update: 16 Jun 2016
At a glance
- Drugs Tocilizumab (Primary)
- Indications Juvenile rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Chugai Pharmaceutical
- 16 Jun 2016 New trial record